Episode Summary

In this conversation, Dr. Lucy McBride hosts Dr. Mary Claire Haver, the renowned board-certified OBGYN from Galveston, Texas. Dr. Haver, author of the bestselling book The New Menopause, discusses the current menopause moment, the complexities of hormone replacement therapy, and why women have been deprived of essential information about their hormonal health for decades. The conversation covers everything from the misinterpretation of the Women's Health Initiative study to practical prescribing guidelines for estrogen, progesterone, and testosterone. Both doctors emphasize that menopause care requires a nuanced, individualized approach that treats the patient, not just the symptoms or lab values.

Key Concepts

The Current "Menopause Moment"

* Social media as catalyst: Dr. Haver explains that social media has become a powerful platform where women share their menopause experiences, creating unprecedented awareness and demand for better care

* Generational shift: Gen X women are refusing to "quietly suffer" through symptoms like vaginal atrophy, bone deterioration, and cognitive decline

* Health span focus: Patients are increasingly concerned with quality of life and preventing the trajectory of decline they witnessed in their mothers and grandmothers

* Caregiver burden awareness: Women are motivated by not wanting to burden their children with preventable chronic illnesses and disabilities

The Women's Health Initiative Legacy and Medical Education Gaps

* Flawed interpretation: The 2002 Women's Health Initiative study wasn't inherently flawed, but its interpretation and media coverage created decades of fear around hormone replacement therapy

* Medical school inadequacy: Both doctors received minimal menopause education—Dr. Haver recalls just one hour in medical school with outdated information

* "Bikini medicine" concept: Dr. Haver describes OB-GYN as focusing primarily on "breast, uterus, vagina" rather than comprehensive women's health

* Guideline conflicts: Current conflicting guidelines between ACOG and the North American Menopause Society create confusion for practitioners

* Systemic healthcare bias: The medical system struggles to address symptoms that can't be measured in blood tests or imaging

Hormone Replacement Therapy: Estrogen Formulations and Prescribing

* Oral vs. transdermal delivery: Oral estrogen carries a small increased risk of blood clots (7 in 10,000) due to first-pass liver metabolism, while transdermal forms (patches, gels, sprays) avoid this risk entirely

* Cardiovascular benefits: Oral estrogen may offer slightly better cardiovascular protection and LDL reduction due to liver metabolism

* Bone protection thresholds: Different estrogen levels provide different benefits—some stop bone degradation while higher levels can actually build bone

* Individual absorption variability: Patients absorb hormones differently, requiring personalized dosing and monitoring

* Cost considerations: Generic patches are often the most affordable option, while newer formulations like gels and rings can be expensive

Progesterone: Beyond Endometrial Protection

* Mandatory for uterus owners: Women with a uterus must take progesterone with estrogen to prevent endometrial overgrowth and cancer risk

* Sleep and anxiety benefits: Progesterone converts to allopregnenolone, which binds to GABA receptors and provides sedative effects

* Multiple delivery options: IUDs can provide local progesterone for endometrial protection while oral progesterone can be added for sleep benefits

* Individual tolerance: Some women experience paradoxical stimulation or next-day grogginess from progesterone

* Newer options: Duavee combines conjugated estrogen with bazedoxifene, a SERM that blocks estrogen receptors in breast and uterine tissue

Testosterone: The Overlooked Hormone

* Age-related decline: Testosterone levels begin declining at age 30 in women, reaching about 50% of peak levels by age 50

* FDA approval gap: Despite multiple medical societies supporting testosterone for low libido treatment, the FDA has not approved any testosterone products specifically for women

* Evidence for libido: Strong evidence supports testosterone use for hypoactive sexual desire disorder in women

* Potential broader benefits: While not definitively proven, observational data suggests women with higher natural testosterone levels have better bone density, muscle strength, and lower frailty scores

* Dosing challenges: Women must use compounded or modified men's formulations due to lack of FDA-approved options

The Zone of Chaos: Understanding Perimenopause

* Clinical diagnosis: Perimenopause is diagnosed based on symptoms and patient history, not blood tests, due to wildly fluctuating hormone levels

* 7-10 year process: The transition from regular cycles to menopause typically takes 7-10 years as egg supply dwindles

* Unpredictable patterns: Unlike the predictable monthly cycle of reproductive years, perimenopause involves erratic hormone fluctuations

* Multiple system effects: Estrogen affects every body system—brain, bones, heart, vagina, mood—making perimenopause symptoms diverse and complex

* Treatment complexity: Managing perimenopause often requires different approaches than treating postmenopausal women, including considerations about contraception needs

The Upshot

This conversation illuminates why menopause care represents one of medicine's most significant gaps in women's health. The combination of inadequate medical education, misinterpreted research, conflicting guidelines, and time-constrained healthcare visits has left millions of women without access to evidence-based treatment. Dr. Haver's work, along with other menopause advocates, is helping to change this narrative by emphasizing that menopause is not just about hot flashes—it's about optimizing health span and preventing the cascade of age-related diseases that disproportionately affect women after menopause.

The key takeaway is that menopause care requires a toolkit approach where hormone replacement therapy is one important tool among many, including nutrition, exercise, stress management, and sleep optimization.

For women who missed the opportunity for hormone therapy during their menopause transition, it's never too late to focus on building better health through lifestyle interventions and appropriate medical care. The goal isn't just living longer—it's about maintaining vitality, independence, and quality of life throughout the aging process.

Most importantly, this conversation underscores the need for women to become educated advocates for their own health, to seek out menopause-knowledgeable providers, and to make decisions based on current evidence rather than outdated fears. As Dr. Haver emphasizes, women armed with good information make great decisions for themselves.

Get full access to Are You Okay? at lucymcbride.substack.com/subscribe